Christine Bellanné-Chantelot Selected Research

Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)

3/2007	Association of CYP1B1 germ line mutations with hepatocyte nuclear factor 1alpha-mutated hepatocellular adenoma.
3/2005	Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas.
1/2005	Diagnosis and management of maturity-onset diabetes of the young.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christine Bellanné-Chantelot Research Topics

Disease

11	Congenital Hyperinsulinism 01/2021 - 02/2004
10	Type 2 Diabetes Mellitus (MODY) 12/2020 - 08/2003
8	Autosomal Recessive 3 Severe Congenital Neutropenia 12/2022 - 06/2004
7	Neoplasms (Cancer) 01/2017 - 01/2005
6	Neutropenia 12/2022 - 01/2005
5	Diabetes Mellitus 10/2010 - 04/2004
4	Hypoglycemia (Reactive Hypoglycemia) 06/2018 - 11/2009
4	Hyperglycemia 11/2009 - 07/2008
4	Hyperinsulinism (Hyperinsulinemia) 02/2009 - 01/2006
3	Infections 03/2024 - 01/2005
3	Cyclic neutropenia 01/2021 - 06/2004
3	Thrombocytosis (Thrombocythemia) 01/2017 - 02/2014
3	Leukemia 02/2013 - 01/2005
3	Hyperplasia 10/2011 - 02/2004
3	Mason-Type Diabetes 11/2009 - 03/2005
3	Renal cysts and diabetes syndrome 07/2007 - 04/2004
2	Warts (Wart) 03/2024 - 12/2022
2	Spontaneous Abortion (Miscarriage) 01/2023 - 03/2010
2	Reinfection 10/2021 - 01/2014
2	Shwachman-Diamond Syndrome 01/2019 - 05/2011
2	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 09/2018 - 01/2015
2	Essential Thrombocythemia 01/2016 - 02/2014
2	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2012 - 12/2007
2	Type 2 Maturity-Onset Diabetes of the Young 07/2008 - 01/2005
2	Atrophy 01/2005 - 04/2004
1	Glycogen Storage Disease (Glycogenosis) 12/2022
1	Hearing Loss (Hearing Impairment) 01/2022
1	severe chronic Neutropenia 01/2021
1	Precocious Puberty 09/2018
1	Insulinoma 06/2018
1	Polycythemia (Erythrocytosis) 01/2018
1	Exocrine Pancreatic Insufficiency 01/2018
1	primary familial and congenital Polycythemia 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Proteinuria 05/2016
1	Polycythemia Vera 01/2016
1	Wounds and Injuries (Trauma) 01/2015
1	Fatigue 01/2015
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2014
1	Cohen syndrome 05/2014

Drug/Important Bio-Agent (IBA)

10	Insulin (Novolin)FDA Link 12/2020 - 02/2004
7	Transcription Factors (Transcription Factor)IBA 10/2016 - 08/2003
7	Hepatocyte Nuclear Factor 1-betaIBA 10/2010 - 04/2004
6	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2021 - 01/2005
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2004
6	KATP ChannelsIBA 01/2021 - 09/2007
6	GlucokinaseIBA 06/2018 - 08/2003
5	Adenosine Triphosphate (ATP)IBA 10/2016 - 09/2007
4	Hepatocyte Nuclear FactorsIBA 11/2017 - 03/2005
4	Glucose (Dextrose)FDA LinkGeneric 10/2011 - 01/2008
3	Chemokine ReceptorsIBA 03/2024 - 01/2014
3	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2023 - 03/2010
3	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2021 - 06/2004
3	Thrombopoietin (c-mpl Ligand)IBA 01/2017 - 02/2014
3	Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA 03/2007 - 01/2005
2	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 12/2022 - 01/2009
2	Amino Acids FDA Link 01/2018 - 01/2008
2	EnzymesIBA 01/2018 - 08/2003
2	Octreotide (Sandostatin)FDA LinkGeneric 02/2012 - 10/2011
2	Diazoxide (Hyperstat)FDA Link 10/2011 - 10/2011
2	Sulfonylurea ReceptorsIBA 04/2011 - 02/2009
2	GlucocorticoidsIBA 03/2010 - 08/2003
2	SteroidsIBA 08/2009 - 09/2007
2	Levodopa (L Dopa)FDA LinkGeneric 12/2007 - 01/2007
1	Testosterone (Sustanon)FDA Link 01/2023
1	Androstenedione (4 Androstene 3,17 dione)IBA 01/2023
1	AndrogensIBA 01/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2022
1	1,5-anhydroglucitolIBA 12/2022
1	EstersIBA 12/2022
1	Sodium-Glucose Transport ProteinsIBA 12/2022
1	Phosphates (Orthophosphate)IBA 12/2022
1	ElementsIBA 01/2022
1	Endopeptidase ClpIBA 01/2022
1	ProinsulinIBA 12/2020
1	GTP Phosphohydrolases (GTPases)IBA 01/2019
1	Peptide Elongation Factors (Elongation Factor)IBA 01/2019
1	SaltsIBA 09/2018
1	Erythropoietin FDA Link 01/2018
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2018
1	DiamondIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	4,5,6,7- tetrahydroisoxazolo(4,5- c)pyridin- 3- ol (THPO)IBA 01/2017
1	Potassium Channels (Potassium Channel)IBA 10/2016
1	intrinsic factor-cobalamin receptorIBA 05/2016
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 05/2016
1	Autophagy-Related ProteinsIBA 03/2016
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2016
1	Thrombopoietin ReceptorsIBA 01/2016
1	CalreticulinIBA 01/2016
1	Cosyntropin (Cortrosyn)FDA LinkGeneric 01/2015
1	Protein Isoforms (Isoforms)IBA 06/2014
1	Membrane Proteins (Integral Membrane Proteins)IBA 05/2014

Therapy/Procedure

10	Therapeutics 12/2022 - 01/2005
2	Pancreatectomy 10/2011 - 12/2007
1	Antibiotic Prophylaxis 10/2021